Claims for Patent: 5,223,243

Summary for Patent: 5,223,243

Title:	Dipyridoxyl phosphate chelating compound intermediates useful as NMRI contrast agents
Abstract:	N,N'-bis-(pyridoxal-5-phosphate)-alkylenediamine-N,N'-diacetic acids, N,N'-bis-(pyridoxal-5-phosphate)-1,2-cycloalkylenediamine-N,N'diacetic acids, and N,N'-bis-(pyridoxal-5-phosphate)-1,2-arylenediamine-N,N'diacetic acids, the corresponding monophosphate compounds and monoacetic acid compounds, and their salts and esters form stable, highly soluble chelates with paramagnetic metal ions, and are highly effective NMRI contrast agents. Preferred contrast agents are paramagnetic ion chelates of N,N'-bis-(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid, N,N'-bis-(pyridoxal-5-phosphate)trans-1,2-cyclohexylenediamine-N,N'-diacetic acid, N,N'-bis-(pyridoxal-5-phosphate)trans-1,2-arylenediamine-N,N'-diacetic acid, and the soluble calcium salts thereof.Novel intermediates for forming these compounds are N,N'-bis(pyridoxal-5-phosphate)alkylenediimines, N,N'-bis(pyridoxal-5-phosphate)alkylenediamines, N,N'-bis(pyridoxal-5-phosphate)-1,2-cycloalkylenediimines, N,N'-bis(pyridoxal-5-phosphate)-1,2-cycloalkylenediamines, N,N'-bis(pyridoxal-5-phosphate)-1,2-arylenediamines, and the corresponding monophosphate compounds.
Inventor(s):	Scott M. Rocklage, Steven C. Quay
Assignee:	Amersham Health Salutar Inc
Application Number:	US07/570,115
Patent Claims:	1. An improvement in the method of performing NMR imaging with a patient, comprising administering to the patient an effective amount of a chelate of a compound of the formula I with a metal ion having an atomic number within the range of 21 to 29, 42, 44, or 58-70: ##STR9## wherein R is hydrogen or ##STR10## R1 is hydrogen or ##STR11## with the proviso that at least one of R and R1 is other than hydrogen;R5 and R6 are each, independently, hydroxy, alkoxy having from 1 to 18 carbons, hydroxy-substituted alkoxy having from 1 to 18 carbons, amino, or alkylamido having from 1 to 10 carbons; R3 is alkylene having from 1 to 8 carbons, 1,2-cycloalkylene having from 5 to 8 carbons, or 1,2-arylene having from 6 to 10 carbons; R4 is hydrogen, hydroxymethyl, alkyl having from 1 to 6 carbons, or ##STR12## each R7 is, independently, hydrogen, hydroxy-substituted alkyl having from 1 to 18 carbons; or a physiologically biocompatible inorganic or organic cation salt of said chelatable compound. 2. A method according to the formula I of claim 1 wherein each R7 is, independently, hydrogen.